| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 258 |
| 1 | METHOTREXATE | 210 |
| 2 | PREDNISOLONE | 105 |
| 3 | PREDNISOLONE ORAL | 105 |
| 4 | PREDNISOLONE ORAL SOLUTION | 105 |
| 5 | PREDNISONE | 84 |
| 6 | CYCLOPHOSPHAMIDE | 72 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 72 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 72 |
| 9 | TACROLIMUS | 43 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | UNDECYLENIC ACID | 1 | 0.0072 |
| 1 | AURANOFIN | 1 | 0.0049 |
| 2 | TOLNAFTATE 1% | 1 | 0.0034 |
| 3 | CHLORAMBUCIL | 7 | 0.0018 |
| 4 | ANAGRELIDE HYDROCHLORIDE | 2 | 0.0017 |
| 5 | MERCAPTOPURINE | 20 | 0.0011 |
| 6 | LISOCABTAGENE MARALEUCEL | 1 | 0.0011 |
| 7 | PENICILLAMINE | 1 | 0.0011 |
| 8 | IFOSFAMIDE FOR INJECTION | 22 | 0.0010 |
| 9 | BREXUCABTAGENE AUTOLEUCEL | 2 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 213 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 208 |
| 2 | Alkylating Drug [EPC] | 84 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 48 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 42 |
| 5 | Purine Antimetabolite [EPC] | 41 |
| 6 | Topoisomerase Inhibitor [EPC] | 37 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 27 |
| 8 | Platinum-based Drug [EPC] | 25 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 11 | 0.0005 |
| 1 | Topoisomerase Inhibitor [EPC] | 37 | 0.0005 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 208 | 0.0005 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 10 | 0.0005 |
| 4 | Purine Antimetabolite [EPC] | 41 | 0.0004 |
| 5 | Asparagine-specific Enzyme [EPC] | 5 | 0.0004 |
| 6 | Alkylating Drug [EPC] | 84 | 0.0003 |
| 7 | CD30-directed Immunoconjugate [EPC] | 3 | 0.0003 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0002 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 27 | 0.0002 |